Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in 
patients with recurrent glioblastoma multiforme

Galldiks, Norbert; Ullrich, Roland; Schroeter, Michael; Fink, Gereon R.; Kracht, Lutz W.

doi:10.1007/s00259-009-1219-5

Lokale TagsFreigabegeschichteDetailsÜbersicht

Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme

Galldiks, N., Ullrich, R., Schroeter, M., Fink, G. R., & Kracht, L. W. (2010). Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. European Journal of Nuclear Medicine and Molecular Imaging, 37(1), 84-92. doi:10.1007/s00259-009-1219-5.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-0026-DAAC-6 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-0026-DAAD-4

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Galldiks, Norbert¹, Autor
Ullrich, Roland¹, Autor
Schroeter, Michael², Autor
Fink, Gereon R.³, Autor
Kracht, Lutz W.¹, Autor

Affiliations:
1Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149663
2Multimodal Imaging of Brain Metabolism, Research Groups, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149667
3Wolf-Dieter Heiss, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149649